| Â | Model 1 | Model 2 | Model 3 |
|---|
| Â | R | P | R | P | R | P |
MoCA | -0.116 | 0.168 | -0.131 | 0.124 | -0.120 | 0.161 |
DST | -0.111 | 0.187 | -0.096 | 0.262 | -0.093 | 0.276 |
VFT | -0.226 | 0.007** | -0.221 | 0.009** | -0.214 | 0.012* |
CDT | -0.037 | 0.664 | -0.013 | 0.876 | -0.024 | 0.780 |
TMTA | 0.086 | 0.306 | 0.078 | 0.364 | 0.056 | 0.511 |
TMTB | 0.261 | 0.002** | 0.253 | 0.003** | 0.241 | 0.004** |
AVLT-IR | -0.111 | 0.185 | -0.122 | 0.152 | -0.115 | 0.178 |
AVLT-DR | -0.139 | 0.098 | -0.154 | 0.070 | -0.150 | 0.079 |
LMT | -0.028 | 0.741 | -0.041 | 0.630 | -0.041 | 0.631 |
- Notes: Model 1 showed the Pearson association between HOMA-IR and cognitive function in patients with T2DM; Model 2 showed the partial correlation between HOMA-IR and cognitive function adjusting for age, gender, duration of DM and hypertension; Model 3 showed the partial correlation between HOMA-IR and cognitive function adjusting for age, gender, duration of DM and hypertension as well as HbA1c. * P < 0.05; ** P < 0.01. Abbreviations: T2DM, type 2 diabetes mellitus; MoCA, Montreal cognitive assessment; DST, digit span test; VFT, verbal fluency test; CDT, clock drawing test; TMTA, trail making test-A; TMTB, trail making test-B; AVLT-IR, auditory verbal learning test-immediate recall; AVLT-DR, auditory verbal learning test-delayed recall; LMT, logical memory test; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin
